Visites | |
---|---|
An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer | 254 |
mayo 2024 | junio 2024 | julio 2024 | agosto 2024 | septiembre 2024 | octubre 2024 | noviembre 2024 | |
---|---|---|---|---|---|---|---|
An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer | 0 | 1 | 0 | 1 | 2 | 2 | 1 |
Visites | |
---|---|
099972.pdf | 117 |
Visites | |
---|---|
Estats Units | 35 |
Alemanya | 8 |
Ucraïna | 8 |
Rússia | 1 |
Suècia | 1 |
Visites | |
---|---|
Ashburn | 13 |
Fairfield | 8 |
Jacksonville | 6 |
Cambridge | 2 |
Chandler | 1 |
Redwood City | 1 |
San Mateo | 1 |